•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S00036 Summary:

BILL NOS00036A
 
SAME ASSAME AS A02145-A
 
SPONSORMAYER
 
COSPNSRHARCKHAM, JACKSON, LIU, MYRIE, RIVERA
 
MLTSPNSR
 
Amd §§6807 & 6810, Ed L
 
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Go to top

S00036 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          36--A
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                       (Prefiled)
 
                                     January 8, 2025
                                       ___________
 
        Introduced  by  Sens.  MAYER,  MYRIE,  RIVERA  -- read twice and ordered
          printed, and when printed to be committed to the Committee  on  Higher
          Education  -- committee discharged, bill amended, ordered reprinted as
          amended and recommitted to said committee

        AN ACT to amend the education law, in relation to the labeling of mifep-
          ristone, misoprostol, and their generic alternatives
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivision  1  of  section  6807 of the education law is
     2  amended by adding a new paragraph b-1 to read as follows:
     3    b-1. Notwithstanding paragraph b of  this  section,  the  prescription
     4  label  for mifepristone, misoprostol, and their generic alternatives may
     5  include the name of the dispensing health care practice instead  of  the
     6  name of the dispenser.
     7    §  2.  Section  6810  of  the education law is amended by adding a new
     8  subdivision 1-a to read as follows:
     9    1-a.  Notwithstanding  subdivision  one  of  this  section,   at   the
    10  prescriber's request, the prescription label for mifepristone, misopros-
    11  tol,  and  their  generic  alternatives  may  include  the  name  of the
    12  prescribing health care practice instead of the name of the prescriber.
    13    § 3. This act shall take effect immediately.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00159-02-5
Go to top